Action of (S)-10-hydroxycamptothecin on P388 leukemia and distribution of the drug in mice.
Cancer Treat Rep
; 67(2): 179-82, 1983 Feb.
Article
in En
| MEDLINE
| ID: mdl-6825126
ABSTRACT
As an inhibitor of the growth of P388 leukemia in mice, (S)-10-hydroxycamptothecin (OPT) was as potent as the parent compound camptothecin (CPT). Incorporation of thymidine into DNA was the parameter most sensitive to OPT in vitro (ED50 approximately 4 micrograms/ml), but incorporation of cytidine into RNA and of acetate into lipids was also reduced significantly in the presence of the drug. The cytofluorometric profile suggested suppression of the S and G2/M phases. The distribution of OPT in mice at 2 and 24 hours after ip injection (10 mg/kg) was essentially similar to that of CPT, with the exception of a somewhat greater concentration of CPT in the liver. In their pharmacology, OPT and CPT appear to be very similar, despite reports that the hydroxy derivative is less toxic.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Camptothecin
/
Leukemia, Experimental
/
Leukemia P388
/
Antineoplastic Agents, Phytogenic
Limits:
Animals
Language:
En
Journal:
Cancer Treat Rep
Year:
1983
Document type:
Article